Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2025)

PROCEPT BioRobotics has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $1.7 million for Q4 2025, up 17.62% from a year ago — trailing twelve months through Dec 2025 was $6.4 million (up 22.09% YoY), and the annual figure for FY2025 was $6.4 million, up 22.09%.
  • Depreciation & Amortization (CF) for Q4 2025 was $1.7 million at PROCEPT BioRobotics, up from $1.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PRCT hit a ceiling of $1.7 million in Q4 2025 and a floor of $642000.0 in Q2 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $984500.0 (2021), compared with a mean of $1.1 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 17.16% in 2022 and later soared 98.79% in 2023.
  • PROCEPT BioRobotics' Depreciation & Amortization (CF) stood at $763000.0 in 2021, then fell by 13.11% to $663000.0 in 2022, then soared by 98.79% to $1.3 million in 2023, then grew by 10.24% to $1.5 million in 2024, then increased by 17.62% to $1.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $1.7 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.